Citigroup Inc. Sells 36,619 Shares of Oscar Health, Inc. $OSCR

Citigroup Inc. reduced its stake in shares of Oscar Health, Inc. (NYSE:OSCR) by 23.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 122,248 shares of the company’s stock after selling 36,619 shares during the quarter. Citigroup Inc.’s holdings in Oscar Health were worth $2,314,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Raiffeisen Bank International AG acquired a new stake in shares of Oscar Health in the 3rd quarter valued at $1,171,000. Maridea Wealth Management LLC acquired a new stake in shares of Oscar Health during the 3rd quarter worth about $331,000. GSA Capital Partners LLP lifted its holdings in Oscar Health by 238.8% during the 3rd quarter. GSA Capital Partners LLP now owns 35,753 shares of the company’s stock valued at $677,000 after purchasing an additional 25,199 shares during the last quarter. Vanguard Group Inc. lifted its holdings in Oscar Health by 2.1% during the 3rd quarter. Vanguard Group Inc. now owns 20,160,399 shares of the company’s stock valued at $381,636,000 after purchasing an additional 423,184 shares during the last quarter. Finally, State of New Jersey Common Pension Fund D acquired a new position in Oscar Health in the third quarter valued at about $2,611,000. 75.70% of the stock is owned by institutional investors.

Analysts Set New Price Targets

OSCR has been the topic of several research analyst reports. Piper Sandler raised shares of Oscar Health from a “neutral” rating to an “overweight” rating and upped their price objective for the stock from $13.00 to $25.00 in a research note on Tuesday, November 25th. Stephens started coverage on shares of Oscar Health in a research note on Thursday, December 11th. They issued an “equal weight” rating and a $17.00 target price for the company. Weiss Ratings reissued a “sell (d)” rating on shares of Oscar Health in a report on Thursday, January 22nd. Wells Fargo & Company decreased their price target on Oscar Health from $14.00 to $11.00 and set an “underweight” rating on the stock in a research report on Thursday, November 13th. Finally, Barclays set a $18.00 price target on Oscar Health and gave the company an “equal weight” rating in a report on Monday, January 5th. Two equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $16.88.

Insiders Place Their Bets

In related news, insider Mario Schlosser sold 76,962 shares of the business’s stock in a transaction that occurred on Tuesday, January 6th. The shares were sold at an average price of $17.01, for a total value of $1,309,123.62. Following the completion of the transaction, the insider owned 350,180 shares in the company, valued at $5,956,561.80. The trade was a 18.02% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. In the last three months, insiders have sold 138,835 shares of company stock valued at $2,298,269. Insiders own 24.39% of the company’s stock.

Oscar Health Trading Down 3.3%

OSCR opened at $13.92 on Friday. The company has a current ratio of 0.96, a quick ratio of 0.96 and a debt-to-equity ratio of 0.44. The stock has a market capitalization of $4.14 billion, a PE ratio of -8.00 and a beta of 1.91. Oscar Health, Inc. has a 1-year low of $11.20 and a 1-year high of $23.80. The firm has a 50-day moving average price of $14.64 and a two-hundred day moving average price of $16.57.

Oscar Health (NYSE:OSCR) last announced its earnings results on Tuesday, February 10th. The company reported ($1.24) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.92) by ($0.32). Oscar Health had a negative return on equity of 39.35% and a negative net margin of 3.79%.The company had revenue of $2.81 billion during the quarter, compared to the consensus estimate of $3.12 billion. During the same period in the prior year, the firm posted ($0.62) earnings per share. The company’s revenue was up 17.3% on a year-over-year basis. As a group, equities analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.